Event Notification Report for December 02, 2004
U.S. Nuclear Regulatory Commission
Operations Center
EVENT REPORTS FOR
12/01/2004 - 12/02/2004
Power Reactor
Event Number: 41239
Facility: RIVER BEND
Region: 4 State: LA
Unit: [1] [] []
RX Type: [1] GE-6
NRC Notified By: KEN HIGGINBOTHAM
HQ OPS Officer: BILL HUFFMAN
Region: 4 State: LA
Unit: [1] [] []
RX Type: [1] GE-6
NRC Notified By: KEN HIGGINBOTHAM
HQ OPS Officer: BILL HUFFMAN
Notification Date: 12/02/2004
Notification Time: 20:10 [ET]
Event Date: 12/02/2004
Event Time: 17:30 [CST]
Last Update Date: 12/02/2004
Notification Time: 20:10 [ET]
Event Date: 12/02/2004
Event Time: 17:30 [CST]
Last Update Date: 12/02/2004
Emergency Class: NON EMERGENCY
10 CFR Section:
50.72(b)(2)(i) - PLANT S/D REQD BY TS
10 CFR Section:
50.72(b)(2)(i) - PLANT S/D REQD BY TS
Person (Organization):
DAVID GRAVES (R4)
DAVID GRAVES (R4)
| Unit | SCRAM Code | RX Crit | Initial PWR | Initial RX Mode | Current PWR | Current RX Mode |
|---|---|---|---|---|---|---|
| 1 | N | Y | 100 | Power Operation | 77 | Power Operation |
TECHNICAL SPECIFICATION SHUTDOWN DUE TO LOSS OF THE DIVISION 2 125 VDC BATTERY CHARGER
"On December 2, 2004, at 17:30 p.m. CST, River Bend Station commenced a plant shutdown required by Technical Specifications. This action was made necessary by the loss of the Division 2 safety-related 125 volt battery charger. The cause of the failure has not been determined. Actions are ongoing to restore the charger to service.
"The pertinent Technical Specification action statement was entered at 1236 CST on 12/02/2004, and requires the plant to be in Mode 3 by 0036 CST on 12/03/2004 and Mode 4 by 0036 CST on 12/04/2004. This event is being report in accordance with 10CFR50.72(b)(2)(i)."
The licensee added that the Division 1 electrical system is available and fully capable of supporting all reactor safety-related protective functions. The licensee is still trouble shooting the cause of the charger malfunction.
The licensee has notified the NRC Senior Resident Inspector.
"On December 2, 2004, at 17:30 p.m. CST, River Bend Station commenced a plant shutdown required by Technical Specifications. This action was made necessary by the loss of the Division 2 safety-related 125 volt battery charger. The cause of the failure has not been determined. Actions are ongoing to restore the charger to service.
"The pertinent Technical Specification action statement was entered at 1236 CST on 12/02/2004, and requires the plant to be in Mode 3 by 0036 CST on 12/03/2004 and Mode 4 by 0036 CST on 12/04/2004. This event is being report in accordance with 10CFR50.72(b)(2)(i)."
The licensee added that the Division 1 electrical system is available and fully capable of supporting all reactor safety-related protective functions. The licensee is still trouble shooting the cause of the charger malfunction.
The licensee has notified the NRC Senior Resident Inspector.
Power Reactor
Event Number: 41240
Facility: SALEM
Region: 1 State: NJ
Unit: [1] [2] []
RX Type: [1] W-4-LP,[2] W-4-LP
NRC Notified By: PAUL ABBOTT
HQ OPS Officer: BILL HUFFMAN
Region: 1 State: NJ
Unit: [1] [2] []
RX Type: [1] W-4-LP,[2] W-4-LP
NRC Notified By: PAUL ABBOTT
HQ OPS Officer: BILL HUFFMAN
Notification Date: 12/02/2004
Notification Time: 21:39 [ET]
Event Date: 12/02/2004
Event Time: 19:30 [EST]
Last Update Date: 12/02/2004
Notification Time: 21:39 [ET]
Event Date: 12/02/2004
Event Time: 19:30 [EST]
Last Update Date: 12/02/2004
Emergency Class: NON EMERGENCY
10 CFR Section:
50.72(b)(2)(xi) - OFFSITE NOTIFICATION
10 CFR Section:
50.72(b)(2)(xi) - OFFSITE NOTIFICATION
Person (Organization):
JAMES TRAPP (R1)
JOSE CALVO (NRR)
ELIOT BRENNER (PAO)
JAMES TRAPP (R1)
JOSE CALVO (NRR)
ELIOT BRENNER (PAO)
| Unit | SCRAM Code | RX Crit | Initial PWR | Initial RX Mode | Current PWR | Current RX Mode |
|---|---|---|---|---|---|---|
| 1 | N | Y | 100 | Power Operation | 100 | Power Operation |
| 2 | N | Y | 100 | Power Operation | 100 | Power Operation |
PRESS RELEASE CONCERNING THE PLANNED SHUTDOWN OF THE SALEM UNITS DUE TO AN OIL SPILL
"PSEG Nuclear announced, via a press release, that based on Delaware River conditions and the potential for oil from the Athos I oil tanker spill to reach the plant circulating and service water intake structures, it has been decided to take both units at the Salem Nuclear Generating Station offline. Hope Creek Generating Station is currently offline in a refueling outage. PSEG Nuclear currently plans to begin reducing power on both Salem Units on Friday December 3, 2004. PSEG Nuclear is continually monitoring river conditions and tracking the progress of the oil spill. Today, PSEG Nuclear began placing booms around the water intake structures at both Salem and Hope Creek nuclear generating stations. The boom is a barrier placed approximately 18 inches deep in the water and is relatively effective in controlling the spread of oil that is on top or close to the surface. However, since the oil spilled in the Delaware River was crude oil, it is expected that the heavier oil might be suspended in the river at varying depths, increasing the potential that oil could reach the plant intake structures. Since the potential exists to adversely impact the plant cooling systems if oil was entrained in the plant cooling water, both Salem 1 and 2 are going to be shutdown.
"This report is being made due to the press release and the possibility that this release will generate public interest. No power reduction has been started at this time. At this time there has been no adverse impact noted on either Salem Unit 1 or 2 due to the oil spill. No injuries have resulted from this condition."
The licensee will notify the NRC Resident Inspector, LAC Township, and representatives of the states of NJ and Delaware.
"PSEG Nuclear announced, via a press release, that based on Delaware River conditions and the potential for oil from the Athos I oil tanker spill to reach the plant circulating and service water intake structures, it has been decided to take both units at the Salem Nuclear Generating Station offline. Hope Creek Generating Station is currently offline in a refueling outage. PSEG Nuclear currently plans to begin reducing power on both Salem Units on Friday December 3, 2004. PSEG Nuclear is continually monitoring river conditions and tracking the progress of the oil spill. Today, PSEG Nuclear began placing booms around the water intake structures at both Salem and Hope Creek nuclear generating stations. The boom is a barrier placed approximately 18 inches deep in the water and is relatively effective in controlling the spread of oil that is on top or close to the surface. However, since the oil spilled in the Delaware River was crude oil, it is expected that the heavier oil might be suspended in the river at varying depths, increasing the potential that oil could reach the plant intake structures. Since the potential exists to adversely impact the plant cooling systems if oil was entrained in the plant cooling water, both Salem 1 and 2 are going to be shutdown.
"This report is being made due to the press release and the possibility that this release will generate public interest. No power reduction has been started at this time. At this time there has been no adverse impact noted on either Salem Unit 1 or 2 due to the oil spill. No injuries have resulted from this condition."
The licensee will notify the NRC Resident Inspector, LAC Township, and representatives of the states of NJ and Delaware.
General Information or Other
Event Number: 46272
Rep Org: OHIO BUREAU OF RADIATION PROTECTION
Licensee: MERCY ST VINCENT MEDICAL CENTER
Region: 3
City: TOLEDO State: OH
County:
License #: 02120490000
Agreement: Y
Docket:
NRC Notified By: STEPHEN JAMES
HQ OPS Officer: MARK ABRAMOVITZ
Licensee: MERCY ST VINCENT MEDICAL CENTER
Region: 3
City: TOLEDO State: OH
County:
License #: 02120490000
Agreement: Y
Docket:
NRC Notified By: STEPHEN JAMES
HQ OPS Officer: MARK ABRAMOVITZ
Notification Date: 09/23/2010
Notification Time: 15:56 [ET]
Event Date: 12/02/2004
Event Time: 00:00 [EDT]
Last Update Date: 09/23/2010
Notification Time: 15:56 [ET]
Event Date: 12/02/2004
Event Time: 00:00 [EDT]
Last Update Date: 09/23/2010
Emergency Class: NON EMERGENCY
10 CFR Section:
10 CFR Section:
Person (Organization):
RICHARD SKOKOWSKI (R3DO)
DUNCAN WHITE (FSME)
RICHARD SKOKOWSKI (R3DO)
DUNCAN WHITE (FSME)
AGREEMENT STATE REPORT - UNREPORTED MEDICAL PROSTATE THERAPY UNDERDOSES DISCOVERED DURING AUDIT
The following information received via email is historical and was discovered/reported to the State of Ohio on 04/27/2010:
"NOTE: The information entered in this event notice was received from the licensee as a result of an audit ordered by the Ohio Department of Health for all brachytherapy procedures performed by the licensee since November 2004. This incident was referenced in Ohio NMED Item # OH100003. [NMED Item Number: 100113 - Ohio Agreement State Report EN #45750]
"On 12/2/04 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [107.4 Gray actually delivered] to the prostate. A post implant dose calculation showed a underdose to the prostate greater than 20% of the prescribed dose; however, the licensee determined the dose to be clinically adequate. No further therapy was planned at that time. [Ohio NMED Item # OH100012]
"On 12/14/04 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [66.27 Gray actually delivered] to the prostate. Post implant dosimetry showed a low dose distribution to the base of the prostate, which was not felt to be clinically significant. No further therapy was recommended at that time, since the patient also received external beam radiotherapy. [Ohio NMED Item # OH100013]
"On 7/3/07 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [101.82 Gray actually delivered] to the prostate. A post implant dose calculation showed a underdose to the prostate greater than 20% of the prescribed dose; however, the licensee determined the dose to be clinically adequate. There was limited dose distribution at the gland base. No further therapy was planned at that time. [Ohio NMED Item # OH100014]
"On 1/11/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [101.7 Gray actually delivered] to the prostate. A post implant dose calculation revealed a suboptimal dose distribution to the base of the prostate gland. No further therapy was planned at that time. [Ohio NMED Item # OH100015]
"On 7/14/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [57.4 Gray actually delivered] to the prostate. Following the final dosimetry testing in 2005, the patient and the referring urologist were notified of a clinically suboptimal dose to the base of the prostate. Post implant prostate volume on which the dosimetry was calculated was 40% greater than the intraoperative prostate volume. Thus, dosimetry was inaccurate due to gland edema. The patient and the referring urologist opted for close monitoring of the prostate and PSA levels without additional therapy. No further therapy was planned at that time. [Ohio NMED Item # OH100016]
"On 4/17/07 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [58.6 Gray actually delivered] to the prostate. Seed implant was utilized as a boost to the prostate gland following IMRT. Post implant dosimetry showed a suboptimal dose distribution at the base; however, satisfactory dose was observed about the mid gland where biopsy proven adenocarcinoma was present. No further therapy was planned at that time. [Ohio NMED Item # OH100017]
"On 9/23/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [79.4 Gray actually delivered] to the prostate. The patient received external beam radiation therapy (4500cGy) and seed implant was utilized as a boost to the prostate gland following IMRT. Post implant dosimetry indicated a clinically satisfactory dose distribution. No further therapy was planned at that time. [Ohio NMED Item # OH100018]"
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.
The following information received via email is historical and was discovered/reported to the State of Ohio on 04/27/2010:
"NOTE: The information entered in this event notice was received from the licensee as a result of an audit ordered by the Ohio Department of Health for all brachytherapy procedures performed by the licensee since November 2004. This incident was referenced in Ohio NMED Item # OH100003. [NMED Item Number: 100113 - Ohio Agreement State Report EN #45750]
"On 12/2/04 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [107.4 Gray actually delivered] to the prostate. A post implant dose calculation showed a underdose to the prostate greater than 20% of the prescribed dose; however, the licensee determined the dose to be clinically adequate. No further therapy was planned at that time. [Ohio NMED Item # OH100012]
"On 12/14/04 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [66.27 Gray actually delivered] to the prostate. Post implant dosimetry showed a low dose distribution to the base of the prostate, which was not felt to be clinically significant. No further therapy was recommended at that time, since the patient also received external beam radiotherapy. [Ohio NMED Item # OH100013]
"On 7/3/07 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [101.82 Gray actually delivered] to the prostate. A post implant dose calculation showed a underdose to the prostate greater than 20% of the prescribed dose; however, the licensee determined the dose to be clinically adequate. There was limited dose distribution at the gland base. No further therapy was planned at that time. [Ohio NMED Item # OH100014]
"On 1/11/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [101.7 Gray actually delivered] to the prostate. A post implant dose calculation revealed a suboptimal dose distribution to the base of the prostate gland. No further therapy was planned at that time. [Ohio NMED Item # OH100015]
"On 7/14/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 160 Gray [57.4 Gray actually delivered] to the prostate. Following the final dosimetry testing in 2005, the patient and the referring urologist were notified of a clinically suboptimal dose to the base of the prostate. Post implant prostate volume on which the dosimetry was calculated was 40% greater than the intraoperative prostate volume. Thus, dosimetry was inaccurate due to gland edema. The patient and the referring urologist opted for close monitoring of the prostate and PSA levels without additional therapy. No further therapy was planned at that time. [Ohio NMED Item # OH100016]
"On 4/17/07 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [58.6 Gray actually delivered] to the prostate. Seed implant was utilized as a boost to the prostate gland following IMRT. Post implant dosimetry showed a suboptimal dose distribution at the base; however, satisfactory dose was observed about the mid gland where biopsy proven adenocarcinoma was present. No further therapy was planned at that time. [Ohio NMED Item # OH100017]
"On 9/23/05 the licensee performed a prostate seed implant with I-125 seeds prescribed to deliver a dose of 108 Gray [79.4 Gray actually delivered] to the prostate. The patient received external beam radiation therapy (4500cGy) and seed implant was utilized as a boost to the prostate gland following IMRT. Post implant dosimetry indicated a clinically satisfactory dose distribution. No further therapy was planned at that time. [Ohio NMED Item # OH100018]"
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.